Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Psychiatry. 2011 May;24(3):237-42. doi: 10.1097/YCO.0b013e328344696b.

Should mild cognitive impairment be subtyped?

Author information

  • 1Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Abstract

PURPOSE OF REVIEW:

To review evidence on the validity and utility of recent approaches to subtyping late-life mild cognitive impairment.

RECENT FINDINGS:

There is growing evidence that amnestic mild cognitive impairment is associated with biomarkers for Alzheimer's disease, while nonamnestic mild cognitive impairment maps more closely to cerebrovascular disease. The former is more likely to progress to dementia than the latter. Mild impairment in multiple cognitive domains appears to represent a more advanced disease state than single-domain impairment, and is more likely to progress to dementia. The cognitive subtypes have imprecise boundaries and have limited ecological validity. Approaches to subtyping that also incorporate biomarkers increase diagnostic specificity and have greater predictive value. However, these approaches have yet to be validated outside specialized memory clinic populations.

SUMMARY:

Mild cognitive impairment as currently defined is still etiologically and prognostically heterogeneous, particularly outside specialty clinical settings. The objective of further subtyping is to delineate subgroups that are more clinically homogeneous. The current cognitive subtypes have some validity and utility but additional approaches should be explored so as to enhance these properties.

PMID:
21346570
[PubMed - indexed for MEDLINE]
PMCID:
PMC3365571
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Write to the Help Desk